ASFD Advantage Target pharmaceutical manufacturers and contract service providers interested in dry powder formulations and advanced delivery systems. Position Engineered BioPharmaceuticals ASFD technology as a means to improve stability, shelf life, and room-temperature storage for complex biologics and small molecules.

Expansion Footprint Leverage the recent Danville facility investments and headcount growth to approach regional biopharma clusters and contract manufacturing organizations (CMOs) seeking scalable, cost-effective production capabilities in the United States.

Nasal Pulmonary Focus Highlight opportunities with medical device companies and biotech firms developing nasal or pulmonary delivery platforms. Offer collaboration on engineered powder formulations tailored for self-administration and non-invasive therapies.

Competitive Differentiation Differentiate from traditional powder manufacturing by emphasizing tunable particle size, density, and aerodynamic properties via ASFD. Target biotech firms pursuing novel delivery routes and stable, room-temperature formulations to reduce cold-chain dependencies.

Tech & Compliance Readiness Leverage existing tech stack and Azure-based infrastructure to propose rapid pilots and scalable production studies. Emphasize regulatory-friendly processes and data management capabilities to attract sponsors seeking disciplined, auditable manufacturing workflows.